DrugPatentWatch Database Preview

Palbociclib - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for palbociclib and what is the scope of palbociclib patent protection?

Palbociclib is the generic ingredient in one branded drug marketed by Pfizer Inc and is included in one NDA. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Palbociclib has seventy-one patent family members in forty-nine countries.

There are thirteen drug master file entries for palbociclib. Two suppliers are listed for this compound.

Summary for palbociclib

International Patents:	71
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	13
Suppliers / Packagers:	2
Bulk Api Vendors:	81
Clinical Trials:	162
Patent Applications:	195
DailyMed Link:	palbociclib at DailyMed

Pharmacology for palbociclib

Drug Class	Kinase Inhibitor
Mechanism of Action	Kinase Inhibitors Cytochrome P450 3A Inhibitors

Synonyms for palbociclib

190P302

2euf

2euf; PD 0332991

571190-30-2

571190-30-2 pound not827022-32-2

6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one

6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one

6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8h-pyrido[2,3-d]pyrimidin-7-one hydrochloride

6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one

6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrido[2,3-d]pyrimidin-7-one

6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino] pyrido[2,3-d]pyrimidin-7-one

6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one

6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE

6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[6,5-d]pyrimidin-7-one

6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one

6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one

6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one

8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one

A1-04309

ABP000842

AC-25485

AC1NS8RV

AHJRHEGDXFFMBM-UHFFFAOYSA-N

AK173631

AKOS022205241

AN-16841

AOB87334

AS-17016

AX8167187

BC654107

BCP09274

BCP9001058

BCPP000125

BDBM6309

BRD-K51313569-001-01-1

C24H29N7O2

CA10003

CHEBI:85993

CHEMBL189963

D10372

DB09073

EBD24067

EX-A408

FT-0697059

G9ZF61LE7G

GTPL7380

HMS3265M09

HMS3265M10

HMS3265N09

HMS3265N10

HY-50767

Ibrance

Ibrance (TN)

KB-79781

KIN0000560

Kinome_3823

Kinome_3824

LQQ

MFCD11840850

MolPort-009-679-393

NCGC00263129-01

NCGC00263129-21

OTAVA-BB 1115529

P-0332991

Palbociclib (JAN/USAN)

Palbociclib [USAN:INN]

Palbociclib free base

Palbociclib(PD0332991)

PD 0332991

PD 0332991,PD0332991

PD 332991

PD 332991, PD 0332991, 827022-32-2

PD-033299

PD-0332991

PD-0332991, PD0332991

PD-0332991/PD0332991,PD332991

PD-332991

PD0332991

PubChem16671

Pyrido-[2,3-d]-pyrimidin-7-one 43

Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-

QCR-200

S14-2748

SC-92588

SCHEMBL462630

UNII-G9ZF61LE7G

X7379

Z-3143

ZINC3938686

US Patents and Regulatory Information for palbociclib

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer Inc	IBRANCE	palbociclib	CAPSULE;ORAL	207103-002	Feb 3, 2015		RX	Yes	No
Pfizer Inc	IBRANCE	palbociclib	CAPSULE;ORAL	207103-001	Feb 3, 2015		RX	Yes	No			Y	Y
Pfizer Inc	IBRANCE	palbociclib	CAPSULE;ORAL	207103-003	Feb 3, 2015		RX	Yes	Yes

International Patents for palbociclib

Country	Patent Number	Estimated Expiration
Japan	2005519909
Dominican Republic	P2003000561
Nicaragua	200300008

Supplementary Protection Certificates for palbociclib

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1470124	1790011-9	Sweden		PRODUCT NAME: PALBOCICLIB, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REG. NO/DATE: EU/1/16/1147 20161111
1470124	300863	Netherlands		PRODUCT NAME: PALBOCICLIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/16/1147 20161111
1470124	17C1012	France		PRODUCT NAME: PALBOCICLIB, ET TOUTES SES FORMES RELEVANT DE LA PROTECTION DU BREVET DE BASE.; REGISTRATION NO/DATE: EU/1/16/1147 20161109